Continuum Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-127
| Closed | -$3.6K | – | 1140 |
|
|
2025
Q1 | $3.6K | Sell |
127
-32
| -20% | -$907 | ﹤0.01% | 1180 |
|
|
2024
Q4 | $6.61K | Sell |
159
-1
| -0.6% | -$42 | ﹤0.01% | 1080 |
|
|
2024
Q3 | $6.36K | Buy |
160
+14
| +10% | +$557 | ﹤0.01% | 1100 |
|
|
2024
Q2 | $17.3K | Buy |
146
+8
| +6% | +$950 | ﹤0.01% | 817 |
|
|
2024
Q1 | $16.9K | Buy |
+138
| New | +$16.9K | ﹤0.01% | 812 |
|
|
2023
Q4 | – | Sell |
-2,206
| Closed | -$228K | – | 474 |
|
|
2023
Q3 | $228K | Sell |
2,206
-215
| -9% | -$22.2K | 0.04% | 404 |
|
|
2023
Q2 | $294K | Sell |
2,421
-616
| -20% | -$74.8K | 0.05% | 369 |
|
|
2023
Q1 | $466K | Sell |
3,037
-324
| -10% | -$49.8K | 0.08% | 270 |
|
|
2022
Q4 | $604K | Sell |
3,361
-89
| -3% | -$16K | 0.11% | 223 |
|
|
2022
Q3 | $408K | Buy |
3,450
+390
| +13% | +$46.1K | 0.07% | 271 |
|
|
2022
Q2 | $437K | Sell |
3,060
-460
| -13% | -$65.7K | 0.08% | 272 |
|
|
2022
Q1 | $473K | Buy |
3,520
+495
| +16% | +$66.5K | 0.09% | 250 |
|
|
2021
Q4 | $768K | Buy |
3,025
+697
| +30% | +$177K | 0.17% | 138 |
|
|
2021
Q3 | $896K | Buy |
2,328
+75
| +3% | +$28.9K | 0.24% | 98 |
|
|
2021
Q2 | $529K | Buy |
2,253
+502
| +29% | +$118K | 0.16% | 140 |
|
|
2021
Q1 | $280K | Buy |
+1,751
| New | +$280K | 0.12% | 143 |
|